The active substance of the medicine is ibuprofen, which works by reducing pain and fever.
The medicine is indicated for use in adults and adolescents over 12 years of age to relieve symptoms of mild or moderate pain, such as headache, toothache, menstrual pain, muscle pain (cramps) or back pain (lower back pain) as well as in febrile conditions and fever and pain after vaccination.
If after 3 days in the case of fever treatment or 3 days in the case of pain treatment in adolescents, or after 5 days in the case of pain treatment in adults, the symptoms worsen or do not improve, a doctor should be consulted.
LT/H/0162/001-002/II/006/G and II/007
in the course of the disease, the immune system attacks the intestines, causing inflammation, which usually leads to bloody diarrhea) or ulcerative colitis, because ibuprofen may exacerbate the course of these diseases.
Before starting treatment with Paduden Express, the patient should discuss it with their doctor or pharmacist:
LT/H/0162/001-002/II/006/G and II/007
Taking anti-inflammatory/pain-relieving medications, such as ibuprofen, may be associated with a small increased risk of heart attack or stroke, especially when used in high doses. The recommended dose should not be exceeded and the duration of treatment should not be prolonged.
Before starting treatment with Paduden Express, the patient should discuss their treatment with their doctor or pharmacist if:
Medicines of this type may cause fluid retention, especially in patients with heart failure and/or high blood pressure (hypertension).
During treatment with ibuprofen, symptoms of an allergic reaction to this medicine have occurred, including difficulty breathing, swelling around the face and neck (angioedema), chest pain. If any of these symptoms are noticed, the patient should stop taking Paduden Express and contact their doctor or emergency medical services immediately.
Severe skin reactions have been reported with the use of ibuprofen, such as exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS) and acute generalized exanthematous pustulosis (AGEP). If the patient experiences any of the symptoms associated with these severe skin reactions described in section 4, they should stop taking Paduden Express and seek medical attention immediately.
Paduden Express may mask the symptoms of infection, such as fever and pain. Therefore, Paduden Express may delay the use of appropriate infection treatment and consequently lead to increased risk of complications. This has been observed in bacterial pneumonia and bacterial skin infections associated with chickenpox. If the patient is taking this medicine during an infection and the symptoms of the infection persist or worsen, they should contact their doctor immediately.
This medicine can be taken with or without food.
Patient with sensitive stomach should take Paduden Express with a meal.
It is recommended to avoid taking ibuprofen with alcohol to avoid stomach damage.
Taking ibuprofen by patients who regularly consume alcohol (at least three servings of alcohol - beer, wine, spirits - per day) may cause stomach bleeding.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a baby, they should consult their doctor or pharmacist before taking this medicine.
LT/H/0162/001-002/II/006/G and II/007
In the first and second trimester of pregnancy, ibuprofen should not be used unless it is clearly necessary, as the use of the medicine may increase the risk of developmental abnormalities or miscarriage. In such cases, the lowest dose should be used for the shortest possible time.
The use of the medicine is contraindicated in the third trimester of pregnancy.
The patient should not take ibuprofen if they are in the last 3 months of pregnancy, as it may harm the unborn baby or cause complications during delivery.
It may cause kidney and heart problems in the unborn baby. It may increase the patient's and their baby's tendency to bleed and cause delayed or prolonged labor. During the first 6 months of pregnancy, the medicine should not be used unless it is absolutely necessary and prescribed by a doctor. If treatment is necessary during this period or when trying to conceive, the smallest dose should be used for the shortest possible time. From the 20th week of pregnancy, ibuprofen may cause kidney function disorders in the unborn baby if taken for more than a few days. This may lead to a decrease in the amount of amniotic fluid surrounding the baby (oligohydramnios) or narrowing of the arterial duct (ductus arteriosus) in the baby's heart. If treatment is necessary for a longer period, the doctor may recommend additional monitoring.
The medicine passes into breast milk, but it can be used during breastfeeding if it is administered in the recommended doses and for the shortest possible period.
In women of childbearing age, it should be considered that the use of medicines containing ibuprofen may cause fertility disorders. The patient should avoid taking this medicine if they are trying to conceive.
Patient who experience dizziness, vision disturbances, or other symptoms while taking this medicine should avoid driving and operating machines.
The medicine may cause allergic reactions.
The medicine contains 51.02 mg of sorbitol in each capsule, which corresponds to 0.73 mg/kg.
The medicine contains less than 1 mmol (39 mg) of potassium per capsule, which means the medicine is considered "potassium-free".
This medicine should always be used exactly as described in this patient leaflet or as directed by the doctor or pharmacist. In case of doubt, the doctor or pharmacist should be consulted.
The recommended dose is:
The smallest effective dose should be used for the shortest period necessary to relieve symptoms. If the symptoms of the infection (such as fever and pain) persist or worsen, the patient should contact their doctor immediately (see section 2).
Method of administration
The medicine is intended for oral use.
The capsules should be swallowed with a small amount of water. The capsules should not be chewed.
Patient with sensitive stomach should take this medicine with a meal.
The medicine is indicated for use in case of pain or fever. If these symptoms disappear, the use of the medicine should be stopped.
If after 3 days in the case of fever treatment or 3 days in the case of pain treatment in adolescents or after 5 days in the case of pain treatment in adults, the symptoms worsen or do not improve, the patient should consult their doctor.
If the patient has taken a larger dose of Paduden Express than recommended or if children have accidentally taken the medicine, they should always contact their doctor or the nearest hospital for advice on the risk and actions to be taken.
Symptoms of overdose may include nausea, abdominal pain, vomiting (which may contain blood), gastrointestinal bleeding (see also section 4 below), diarrhea, headache, ringing in the ears, confusion, and nystagmus. It may also cause agitation, drowsiness, disorientation, or coma. Seizures may occur in some cases. After taking a large dose of the medicine, drowsiness, chest pain, palpitations, loss of consciousness, seizures (mainly in children), weakness, and dizziness, blood in the urine, low potassium levels in the blood, feeling cold, and breathing difficulties have been observed. Additionally, the prothrombin time/INR may be prolonged, probably due to the effect on the activity of circulating blood clotting factors. Acute kidney failure and liver damage may occur. In patients with asthma, worsening of asthma symptoms is possible. Furthermore, low blood pressure and slowed breathing may occur.
Activated charcoal should be administered if the patient has taken a significant amount of the medicine. Gastric lavage should be considered only within 60 minutes of taking a significant amount of the medicine.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The likelihood of side effects increases in patients over 65 years of age. The occurrence of side effects is less common in the case of short treatment duration and when the daily dose is less than the maximum recommended dose.
symptoms of gastrointestinal bleeding, such as: severe abdominal pain, black or tarry stools, and vomiting blood or dark particles resembling coffee grounds.
LT/H/0162/001-002/II/006/G and II/007
Frequent(may affect up to 1 in 10 people):
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people):
Very rare(may affect up to 1 in 10,000 people):
LT/H/0162/001-002/II/006/G and II/007
Frequency not known(frequency cannot be estimated from the available data):
Taking such medicines as Paduden Express may be associated with a small increased risk of heart attack (myocardial infarction) or stroke. During treatment with Paduden Express, prolonged bleeding time, fluid retention (edema), high blood pressure, and heart failure have also been reported.
Based on the experience with the use of NSAIDs, it cannot be excluded that cases of interstitial nephritis (kidney disease), nephrotic syndrome (a disorder characterized by the presence of protein in the urine and edema), and kidney failure may occur.
If the patient experiences any side effects, including those not listed in this leaflet, they should inform their doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw; phone: +48 22 492 13 01; fax: +48 22 492 13 09; website: https://smz.ezdrowie.gov.pl.
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, it is possible to gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Store in a temperature below 30°C.
Do not use this medicine after the expiry date stated on the blister and carton after "EXP". The expiry date refers to the last day of the month stated.
LT/H/0162/001-002/II/006/G and II/007
Do not use this medicine if there are visible signs of capsule damage.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substance of the medicine is ibuprofen. Each soft capsule contains 200 mg of ibuprofen.
The other ingredients are:
Core of the capsule: macrogol 600, potassium hydroxide, purified water
Cap of the capsule: gelatin, sorbitol liquid, partially dehydrated (E 420), tartrazine (E 102), and medium-chain triglycerides
Paduden Express is a soft gelatin capsule, oval in shape (approximately 14 mm x 8 mm), yellow in color, filled with a clear solution.
Paduden Express is available in packs containing 10, 20, or 30 soft capsules in PVC/PVDC/Aluminum blisters in a cardboard box. Not all pack sizes may be marketed.
Ranbaxy (Poland) Sp. z o.o.
ul. Idzikowskiego 16
00-710 Warsaw
phone: 22 642 07 75
Laboratorios Liconsa S.A.
Pol. Ind. Miralcampo, Avenida Miralcampo nº7
19200, Azuqueca de Henares (Guadalajara)
Spain
Terapia S.A.
Strada Fabricii 124
400632 Cluj-Napoca, Cluj
Romania
Lithuania: Ibuprofen NVT 200 mg soft capsules
Estonia: Ibuprofen NVT
Romania: PADUDEN Express 200 mg soft capsules
Poland: Paduden Express
Date of last revision of the leaflet:29.05.2025
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.